(R)-6-Amino-5-((1-(2,6-dichloro-3-fluorophenyl)ethyl)thio)-1'-methyl-[3,4'-bipyridin]-2'(1'H)-one

ID: ALA4527991

PubChem CID: 155544550

Max Phase: Preclinical

Molecular Formula: C19H16Cl2FN3OS

Molecular Weight: 424.33

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](Sc1cc(-c2ccn(C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl

Standard InChI:  InChI=1S/C19H16Cl2FN3OS/c1-10(17-13(20)3-4-14(22)18(17)21)27-15-7-12(9-24-19(15)23)11-5-6-25(2)16(26)8-11/h3-10H,1-2H3,(H2,23,24)/t10-/m1/s1

Standard InChI Key:  HZJCIRZWOWSMOU-SNVBAGLBSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    4.3776  -22.4480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3764  -23.2675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0845  -23.6765    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7941  -23.2670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7913  -22.4444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0827  -22.0391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6705  -22.0352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6723  -21.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9685  -20.8087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2585  -21.2140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2567  -22.0321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9650  -22.4450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5025  -23.6745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9714  -19.9915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4975  -22.0331    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.4944  -21.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2006  -20.8047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9051  -21.2141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6107  -20.8035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6081  -19.9855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8939  -19.5797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1911  -19.9926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7851  -20.8100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9053  -22.0313    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.4795  -19.5909    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    9.3198  -21.2098    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.5523  -20.8029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  1  7  1  0
  4 13  1  0
  9 14  2  0
  5 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 16 23  1  6
 18 24  1  0
 22 25  1  0
 19 26  1  0
 10 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4527991

    ---

Associated Targets(Human)

KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 424.33Molecular Weight (Monoisotopic): 423.0375AlogP: 5.33#Rotatable Bonds: 4
Polar Surface Area: 60.91Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.69CX LogP: 4.22CX LogD: 4.21
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.45Np Likeness Score: -1.20

References

1. Chen W, Guo X, Zhang C, Ke D, Zhang G, Yu Y..  (2019)  Discovery of 2-aminopyridines bearing a pyridone moiety as potent ALK inhibitors to overcome the crizotinib-resistant mutants.,  183  [PMID:31569004] [10.1016/j.ejmech.2019.111734]

Source